刘万超,王 荣

注意缺陷多动障碍是抽动障碍儿童常见的共患病之一，共患注意缺陷多动障碍可能加重抽动障碍的严重程度及影响治疗和预后；若不及时治疗，可能会对儿童日常功能的多个方面产生不良影响，因此合理选择治疗方案极为重要。本文对目前国内外常用的药物进行简要阐述，为更好的治疗抽动障碍共患注意缺陷多动障碍提供相关参考和帮助。

抽动障碍；注意缺陷多动障碍；共患病；药物治疗

[1] Vermilion J, Mink JW. Tic Disorders. Pediatr Rev. 2023 May 1;44(5):294-296. [2] Drechsler R, Brem S, Brandeis D, Grünblatt E, Berger G, Walitza S. ADHD: Current Concepts and Treatments in Children and Adolescents. Neuropediatrics. 2020 Oct;51(5):315-335. [3] Rajaprakash M, Leppert ML. Attention-Deficit/Hyperactivity Disorder. Pediatr Rev. 2022 Mar 1;43(3):135-147. [4] Ogundele MO, Ayyash HF. Review of the evidence for the management of co-morbid Tic disorders in children and adolescents with attention deficit hyperactivity disorder. World J Clin Pediatr. 2018 Feb 8;7(1):36-42. [5] Arnsten AF. The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2010 Oct;10(10):1595-605. [6] Zeng KD, Wang GL, Yuan Y, Zhang W, Huang XH, Hu B. Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder. Eur Rev Med Pharmacol Sci. 2023 May;27(9):4232-4238. [7] 李国凯,黄欣欣等.可乐定透皮贴治疗中重度抽动障碍共患注意缺陷多动障碍儿童的近期疗效[J].海峡药学,2022,34(06):64-66. [8] Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev. 2013 Jul;37(6):1162-71. [9] Groom MJ, Cortese S. Current Pharmacological Treatments for ADHD. Curr Top Behav Neurosci. 2022;57:19-50. [10] Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001 Jul;158(7):1067-74. [11] Yu S,Shen S,Tao M.Guanfacine for the Treatment of Attention Deficit Hyperactivity Disorder: An Updated Systematic Review and Meta-Analysis.J Child Adolesc Psychopharmacol.2023 MAR; 33(2):40-50. [12] Murphy TK, Fernandez TV, Coffey BJ, Rahman O, Gavaletz A, Hanks CE, Tillberg CS, Gomez LI, Sukhodolsky DG, Katsovich L, Scahill L. Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders. J Child Adolesc Psychopharmacol. 2017 Nov;27(9):762-770. [13] 方拴锋,朱晓华,叶蓓等.盐酸托莫西汀治疗儿童多动症合并短暂性抽动障碍的临床疗效及安全性评价［J］.中国临床药药理学杂志,2016,32(8):678-680. [14] 陈静.盐酸托莫西汀治疗儿童注意缺陷多动障碍合并抽动障碍的临床效果[J].内蒙古医学杂志,2020,52(07):809-810. [15] 杜杨.盐酸托莫西汀治疗儿童注意缺陷多动障碍伴抽动障碍的疗效探讨[J].中国现代药物应用,2022,16(19):159-161. [16] Gadow KD, Sverd J,Nolan EE,Sprafkin J,Schneider J. Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46:840–848. [17] Hutson PH, Pennick M, Secker R. Preclinical pharmacokinetics, pharmacology and toxicology of lis-dexamfetamine: a novel d-amphetamine pro-drug.Neuropharmacology. 2014;87:41–50. [18] Quintero J,Gutiérrez-Casares JR,Álamo C. Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review. Neurol Ther. 2022 Dec;11(4):1489-1517.

点击下载PDF